In 2011, Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.

BACKGROUND: The endocannabinoid system is a possible target in the treatment of eating disorders. We used positron emission tomography to investigate the type 1 cannabinoid receptor (CB1R) in bulimic and anorectic patients.

You can read the full article here => https://www.ncbi.nlm.nih.gov/pubmed/21718968